Edward Shatzen

1.4k total citations
14 papers, 1.1k citations indexed

About

Edward Shatzen is a scholar working on Nephrology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Edward Shatzen has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 6 papers in Genetics and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Edward Shatzen's work include Parathyroid Disorders and Treatments (10 papers), Genetic Syndromes and Imprinting (6 papers) and Vitamin D Research Studies (5 papers). Edward Shatzen is often cited by papers focused on Parathyroid Disorders and Treatments (10 papers), Genetic Syndromes and Imprinting (6 papers) and Vitamin D Research Studies (5 papers). Edward Shatzen collaborates with scholars based in United States, Australia and Germany. Edward Shatzen's co-authors include David L. Lacey, David P. Martin, Charles M. Henley, Russell C. Cattley, Gerald Miller, Victoria Shalhoub, Sabrina C. Ward, Xiaodong Li, Sheila Scully and William G. Richards and has published in prestigious journals such as Journal of Clinical Investigation, Kidney International and The Journal of Infectious Diseases.

In The Last Decade

Edward Shatzen

14 papers receiving 1.0k citations

Peers

Countries citing papers authored by Edward Shatzen

Since Specialization

Citations

This map shows the geographic impact of Edward Shatzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Shatzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Shatzen more than expected).

Fields of papers citing papers by Edward Shatzen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Shatzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Shatzen. The network helps show where Edward Shatzen may publish in the future.

Co-authorship network of co-authors of Edward Shatzen

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Shatzen. A scholar is included among the top collaborators of Edward Shatzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Shatzen. Edward Shatzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Cinacalcet attenuates hypercalcemia observed in mice bearing either Rice H-500 Leydig cell or C26-DCT colon tumors 2013 ·European Journal of Pharmacology ·(unknown), Edward Shatzen, B Wiemann, Charlie Starnes, Sheila Scully, Charles M. Henley, David P. Martin	16
2	FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality 2012 ·Journal of Clinical Investigation ·Victoria Shalhoub, Edward Shatzen, Sabrina C. Ward, James Davis, Jennitte Stevens, Vivian Bi, (unknown), Nessa Hawkins, Wei Wang, Ching Chen, (unknown), Russell C. Cattley, Thomas J. Wronski, (unknown), Xiaodong Li, Charles M. Henley, Michael Eschenberg, William G. Richards	309
3	Discovery of a Calcimimetic with Differential Effects on Parathyroid Hormone and Calcitonin Secretion 2011 ·Journal of Pharmacology and Experimental Therapeutics ·Charles M. Henley, Yuhua Yang, James M. Davis, (unknown), Sean Morony, Wei Fan, Monica Florio, Banghua Sun, Edward Shatzen, James K. Pretorius, William G. Richards, David J. St. Jean, Christopher Fotsch, Jeff D. Reagan	25
4	Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD 2011 ·Nephrology Dialysis Transplantation ·Gerald Miller, James M. Davis, Edward Shatzen, (unknown), David P. Martin, (unknown)	33
5	Chondro/osteoblastic and cardiovascular gene modulation in human artery smooth muscle cells that calcify in the presence of phosphate and calcitriol or paricalcitol 2010 ·Journal of Cellular Biochemistry ·(unknown), Edward Shatzen, Sabrina C. Ward, Ji-Young Cha, Michael Boedigheimer, (unknown), Jennifer McNinch, Sheila Scully, (unknown), Dustin Baker, (unknown), (unknown), Zaifa Pan, (unknown), David P. Martin	25
6	The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats 2009 ·European Journal of Pharmacology ·Charles M. Henley, James M. Davis, Gerald Miller, Edward Shatzen, (unknown), Xiaodong Li, David P. Martin, Wei Yao, Nancy E. Lane, Victoria Shalhoub	44
7	Calcification Inhibitors and Wnt Signaling Proteins Are Implicated in Bovine Artery Smooth Muscle Cell Calcification in the Presence of Phosphate and Vitamin D Sterols 2006 ·Calcified Tissue International ·(unknown), Edward Shatzen, (unknown), Michael Boedigheimer, Jennifer McNinch, Raffi Manoukian, (unknown), (unknown), (unknown), (unknown), (unknown), Sabrina C. Ward, David L. Lacey, David P. Martin	38
8	The Receptor Activator of Nuclear Factor-κB Ligand Inhibitor Osteoprotegerin Is a Bone-Protective Agent in a Rat Model of Chronic Renal Insufficiency and Hyperparathyroidism 2005 ·Calcified Tissue International ·(unknown), (unknown), Victoria Shalhoub, Paul Kostenuik, Sean Morony, L. Munyakazi, (unknown), (unknown), Edward Shatzen, Zhaopo Geng, Hong‐Lin Tan, Colin R. Dunstan, David L. Lacey, David P. Martin	23
9	Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism 2005 ·Kidney International ·(unknown), Edward Shatzen, Gerald Miller, Catherine Stehman‐Breen, Michihito Wada, David L. Lacey, David P. Martin	130
10	1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar®/Mimpara®) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism 2005 ·Nephrology Dialysis Transplantation ·Charles M. Henley, (unknown), Russell C. Cattley, Edward Shatzen, Dwight A. Towler, David L. Lacey, David P. Martin	109
11	Pharmacodynamics of the Type II Calcimimetic Compound Cinacalcet HCl 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Edward F. Nemeth, Haynes Heaton, Michael A. Miller, John Fox, Manuel F. Balandrin, Bradford C. Van Wagenen, (unknown), (unknown), J Scherrer, Edward Shatzen, Gilbert M. Rishton, Sheila Scully, Meiying Qi, Robert Z. Harris, David L. Lacey, David E. Martin	286
12	Filgrastim Restores Interleukin‐2 Production in Blood from Patients with Advanced Human Immunodeficiency Virus Infection 1998 ·The Journal of Infectious Diseases ·Thomas Härtung, David Pitrak, MaryAnn Foote, Edward Shatzen, (unknown), Albrecht Wendel	22
13	Recombinant Human Protease Nexin-1 Prevents Articular Cartilage-Degradation in the Rabbit 1993 ·Birkhäuser Basel eBooks ·Paul Stevens, Randy W. Scott, Edward Shatzen	9
14	Synergism of basic fibroblast growth factor and interleukin-1β to induce articular cartilage-degradation in the rabbit 1991 ·Inflammation Research ·Paul Stevens, Edward Shatzen	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact